For instance, targeting OXPHOS with agents like metformin has been shown to induce ferroptosis in AML, with stronger effects observed in specific genetic subtypes such as those with IDH2 and FLT3 mutations. The gene discussed is FLT3; the disease is acute myeloid leukemia.